Join our expert trendspotters as they explore the latest global drug development trends, highlight companies making bold statements in R&D, and reveal which therapeutic categories are en vogue right now – plus so much more.
- Explore the size and shape of the 2025 global drug pipeline
- Review key drug launches and success stories from 2024
- See which companies, therapies, and targets are leading R&D
- Learn where innovation is happening in rare diseases and novel tech
- Get expert picks for the most anticipated drug approvals in 2025
IAN LLOYD
Senior Director for Pharmaprojects
For 33 years, Ian has been the chief author of the annual Pharma R&D Review. His data-driven insights and unique perspective are a staple in the pharmaceutical calendar. Our webinar is your opportunity to put your questions directly to Ian, and uncover new insights that could unlock your future strategy.
ALEXANDRA SHIMMINGS
Executive Editor, Citeline Commercial
As the head of our European editorial team, Alex has covered breathroughs in R&D across a range of therapeutic areas, including infectious diseases, cardiology and cancer. She frequently interviews key players in the industry, keeping her finger on the pulse of the global pharma R&D landscape.